Tirzepatide: what the semaglutide programs we already checked actually charge for it

Sprout Health is a LegitScript-certified telehealth brand that pairs a low compounded entry point with a genuine brand-name route. Compounded semaglutide starts at $149/month and tirzepatide at $199/month (company-stated) and, unlike most compounders, it also offers a real brand-name Wegovy/Zepbound path. Intake is deliberately low-friction: no labs are required and often no telehealth visit either, so the start is close to frictionless. The trade-offs are transparency and scope — the compounded product is 503A-style and not FDA-approved, it is injectable only with no oral route, there is no named medical director, and state availability is gated behind a quiz.

A budget-first telehealth brand, and as of mid-2026 a more credible one than its price suggests. You complete an online intake, a licensed clinician signs off, and compounded semaglutide ships overnight, free, in all 50 states. Two things separate it from the usual cheap-sticker operator: it NAMES its compounding pharmacies — VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request — and it names the clinical network behind the prescriptions, Arora Health, along with its medical director. The price is flat at every dose. The catch is the commitment: $99 and $125 are annual-plan rates, and Trimi publishes no month-to-month figure at all.

Gala GLP-1 (operated by AI Coaching, Inc., with care delivered through OpenLoop-affiliated medical groups) is built as a women's brand — its pages read “for Women” and “dosed for women's bodies” — and it runs an online intake with clinician review, LegitScript-verified, prescribing in all 50 states as a bare claim with no state list published. It carries compounded semaglutide and tirzepatide, injection only, with no oral or sublingual route yet. Its prices sit on the public page rather than behind the intake, which is worth something — but read the asterisk. Every compounded figure on the page, $179/month for all doses and $149/month for the microdose alike, is footnoted “Price calculated based on a yearly subscription plan”, and the only other number the site gives is a $199/month FAQ rate on a three-month plan. Nothing is priced by the month. There is also a real brand-name door — FDA-approved Ozempic at $1,299/month cash — and a full HRT and menopause line under the same roof.

A compounded-only telehealth brand that leans on clear, published tiers rather than a hidden membership. Compounded semaglutide is $212/month — with a discounted $112 first month — and the price does not step up as you titrate to a higher dose. Care includes provider oversight and lab testing on a roughly six-month cadence, and there's a NAD+ add-on for people who want the longevity adjacency. It carries no brand-name or oral option, and it does not publish which states it serves.

A physician-supervised telehealth clinic for medical weight loss whose stand-out credential is LegitScript certification (#50087439) — an independent verification most compounded-semaglutide sellers do not carry. It fills compounded semaglutide (and tirzepatide) from U.S. pharmacies with transparent, no-insurance monthly pricing, and is one of the few brands we log that offers an oral semaglutide tablet alongside the usual injectable. The trade-offs are the usual compounded caveat plus a thin public site: some tiers are company-stated, the brand Ozempic route is an expensive pass-through, and the serviced-state count is not published.

A compounded-only telehealth brand whose pitch is format choice: sublingual semaglutide as well as the usual injectable, plus tirzepatide. Pricing is all-inclusive — medication, nurse support, shipping and follow-ups in one monthly rate, with no membership, no separate consult fee and cancellation at any time — and the injectable rates are published plainly on the product pages, holding flat whether you buy a 30- or a 90-day supply. Two things to go in knowing. The sublingual option that makes this brand interesting is not in the shop at all; it appears only in an FAQ answer, so the cheapest route is also the least documented. And the site does not agree with itself about its own size.

A compounded GLP-1 and longevity telehealth brand ("A New Era of Personalized Health") that publishes its prices openly rather than hiding them behind a quiz — a genuine plus, since many compounded rivals do not. You complete an online intake, a licensed clinician reviews it, and compounded semaglutide (or tirzepatide) ships as a weekly injectable. It carries both GLP-1 molecules and layers on a wider wellness menu — NAD+ and microdosing protocols — plus an optional Optimum membership that adds 1:1 coaching, a nutritionist, at-home lab draws and wearables. yourEra markets a 50-state licensed-clinician network with no insurance required and HSA/FSA accepted. The trade-offs are mid-market pricing, a compounded-only and injectable-only lineup, and a thin independent footprint — its 50-state and efficacy claims are self-reported.

Telos Rx (operated by Superior Health Solutions LLC) is a broad compounded-telehealth platform whose standout credential is LegitScript certification — an independent verification that most compounded-semaglutide sellers simply do not carry. Beyond GLP-1 it runs a wide menu: semaglutide and tirzepatide in both oral and microdosed formats, intranasal NAD+, recovery and growth-hormone peptides, and bioidentical HRT. The GLP-1 headline is genuinely low — microdosed semaglutide from about $49/month and tirzepatide from about $99/month — but those figures are annual-plan rates, so the cheapest numbers require a 6–12 month commitment, and pricing outside the GLP-1 line is quote-based rather than posted.

Bodybuilding Health+ is the compounded-telehealth arm of Bodybuilding.com — a licensed brand extension operated by Dynamo Group LLC that launched around April 2026. You complete an online intake, an independent licensed provider reviews it, and compounded semaglutide or tirzepatide is filled by a U.S. compounding pharmacy. Its GLP-1 pricing is public, and the two ladders run in opposite directions: semaglutide is $179 the first month (regularly $279) and genuinely steps down to $139/month on a 12-month bundle, while tirzepatide starts at $209/month month-to-month and its bundles cost more per month rather than less — $286, $250 and $244 at three, six and twelve months. Around the GLP-1 line sits an unusually deep menu for the lifter/longevity crowd — NAD+, sermorelin, ED and a broad peptide catalog. The trade-offs are newness and policy: it is only months old with a thin, mixed review record, and prescription orders are final sale.

Asynchronous telehealth: a U.S.-licensed physician reviews an online intake, usually inside a business day, and in many states no phone consultation is required at all. The distinguishing feature is route — the same semaglutide is sold as a sublingual lozenge or a weekly injection, and the lozenge is the cheaper of the two at $99/mo, so choosing the needle-free option costs less rather than more. Free physician visit, free shipping and free follow-up care are bundled instead of billed separately.

A deliberately stripped-back offer, on Oak's own account: you buy a one- or three-month package rather than joining a subscription, there is no membership fee stacked on the medication, and the price is meant to be the same at every dose, so titrating up never raises the bill. Those are Oak's claims about its own structure, and its pricing pages do not let you check a single one of them. Across the homepage, the weight-loss page, two FAQs and the meta description, Oak publishes nine different “starting” figures for compounded semaglutide and compounded tirzepatide and attaches no term or billing cadence to any of them. The two the homepage leads with sit directly beneath a “$200 off — new patient offer”, and Oak's own description of that discount is “$50 off your first month, $200 off 3-months” — so the headline is a three-month package rate, not a monthly one. The undiscounted floors Oak prints elsewhere on the same site are $190/mo on the weight-loss page and $167/mo in the homepage comparison table, and those two contradict each other. The rate you would actually be charged only appears after a 29-question health questionnaire. Approval is same-day with no video call required. Available in all 50 states, and the intake is offered in Spanish as well as English.

A weight-loss platform rather than a single-format prescriber: compounded semaglutide and tirzepatide injections sit alongside GLP-1 liquid drops, lozenges and a daily oral pill, and genuine brand Wegovy and Zepbound are available for anyone who wants the FDA-approved product. Health coaching comes with the membership rather than being sold separately, and the company advertises a 120-day weight-loss guarantee. GLP-1s are prescribed in all 50 states.

A LegitScript-certified nationwide program whose pricing only appears once you are inside the intake — the public site advertises weight-loss injections from $199 without naming which molecule that buys. What you get is genuinely all-in: consult, medication, supplies, shipping and support in one figure, with nothing charged until a provider has approved you and the consult free if you proceed. The catch is dose. Every quoted figure is for the lowest dosage, and the funnel says outright that higher doses may cost more, so the number you see at signup is a floor rather than the price of a therapeutic dose.

A telehealth weight-management platform offering compounded semaglutide in two routes — a weekly injection and an oral dissolving tablet — alongside compounded tirzepatide, four branded pens (Wegovy, Ozempic, Mounjaro, Zepbound) and sermorelin. Onboarding is a two-minute quiz reviewed by a licensed provider. The catalog is genuinely broad; what is missing is any price. Nothing on the public site quotes a figure for any product, its pricing page returns a 404, and every route to a number runs through the intake. Two further claims on its own homepage do not survive reading the rest of it.

Peter MD is a physician-prescribed telehealth brand headquartered in Miami, FL, operating since 2021. Its compounded semaglutide is sold under the name "GLP1 + B12" (semaglutide compounded with B12) on a two-tier structure: $149/month for first-time patients and $139/month for returning patients, each covering a several-week supply at a different total cost. Beyond semaglutide it runs a genuinely broad menu under one account — compounded tirzepatide, sermorelin, NAD+ and TRT — so a patient who wants to add or switch treatments does not need a second provider. The marketing page states plainly that the program is not available in AL, ID, AK or HI; the underlying affiliate program's own state-exclusion data separately confirms AL and ID for semaglutide specifically. Its Terms carry a section literally headed "Pharmacy Disclosure" naming Absolute Pharmacy and Partell Pharmacy with addresses and phone numbers, though no facility class is stated for either and customer reviews are mixed.

A telehealth weight-loss shop selling compounded semaglutide and compounded tirzepatide, each as a weekly injection, a sublingual form and a daily tablet, plus separately priced lower-dose microdose lines. Intake is fully online; providers are stated to be US-based, licensed and board certified, and medication is dispensed through 503A pharmacies. Unlimited provider messaging and free shipping are included, and you are not charged if the provider decides you do not qualify. What the public pages do not make clear is that every price they show is the twelve-month rate: the tirzepatide headline reads “Starting at $299/mo” while the month-to-month rung is $399, and that same twelve-month figure is what the site publishes as the price in its structured data, so search engines are handed it too. It also runs marketing pages for Wegovy, the Foundayo pill, Mounjaro and Zepbound, none of which can actually be bought.

RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, running weight loss alongside separate longevity, hair-loss and sexual-health lines. It compounds semaglutide and tirzepatide in two routes each — a weekly injection and a daily oral capsule, both priced the same within a molecule — and, unusually for this site, it will also dispense the genuine FDA-approved product: Ozempic, Wegovy, Zepbound and Mounjaro are all sold, at brand pricing, beside the compounded line. It names all four of its 503A compounding partners on the homepage with phone numbers, which most of this field does not, and it names the physician behind the practice rather than an anonymous medical team. Intake is a short online assessment with no labs and no video visit, it serves all 50 states, and it is LegitScript-certified. Two things to read carefully. Every product card shows its price labeled "(For the first month)" and does not say what month two costs — the recurring figure is inside the plan picker. And the cheaper numbers on the page are commitment rates: $194/mo semaglutide is twelve months paid up front, against $249 month to month.

An online weight-loss program selling compounded semaglutide and compounded tirzepatide as once-weekly B12 injections, plus tirzepatide as daily sublingual drops. A five-minute questionnaire goes to a US-licensed clinician who reviews it within 24–48 hours; if approved, a starter dose ships with a 16-week titration schedule, all supplies included, and unlimited clinician messaging. It is unusually specific about who is behind the medicine for a program at this price: the compounding pharmacy is named (The Pharmacy Hub, Miami, Florida), the prescribing practice and physician are named with an NPI, and the terms state outright that controlled substances are never prescribed. The pricing page is the opposite of specific. Each of the three formats runs a four-rung ladder from month-to-month up to a year paid in advance, and the figures the page leads with — a hero rate and two “Entry Price” cards — are all yearly rungs printed as monthly ones. A resetting 24-hour countdown sits above them. Separately, the company's own public storefront sells the same injection as a one-time month's supply at a fraction of the plan rate, which the plan page does not mention.

WellMedr is a telehealth weight-loss brand — legal entity Wellmedr LLC, clinical work carried out by OpenLoop Healthcare Partners, PC and its state professional corporations — selling compounded semaglutide as a once-weekly injection or a once-daily dissolving tablet, compounded tirzepatide in the same two routes, brand-name Ozempic and Zepbound at brand pricing, and a separate eight-product microdose line blending a GLP-1 with NAD+, B12 or methionine. It answers two questions a compounded seller often leaves open: it names the pharmacy that fills the prescription, Mycelium Pharmacy, in a standing disclaimer carried on every product page, and it names the medical group and the individual state entities that employ the prescriber. It also puts the compounding caveat on the pricing page rather than a footer, alongside the thyroid C-cell and medullary-thyroid-carcinoma warnings. The pricing is the opposite of forthcoming. The semaglutide card leads with a monthly-looking figure that the site's own banner elsewhere identifies as the twelve-month lock-in rate; the plan ships every four weeks rather than every month; the refund policy names a third renewal interval again; and the rate you would pay buying a single month only appears inside the intake, because both plan buttons open a checkout app that will not load without a plan already chosen. One thing this site is specifically careful about, it is careful about on the other molecule: the tirzepatide card promises the price does not move with the dose, and the semaglutide card makes no such promise either way.

A cash-pay telehealth selling compounded semaglutide and tirzepatide in twelve-week blocks, priced publicly before any intake. There is no month-to-month option: the block is the only cadence, paid up front, with a reduced first four weeks on each molecule. It also runs a Spanish-language lander alongside the English site.

MEDGm is a Delaware-registered telehealth platform selling compounded semaglutide and compounded tirzepatide by injection, plus semaglutide as an oral tablet, prescribed through OpenLoop Healthcare Partners, PC and its state affiliates. Its terms carry a pharmacy-partners section listing four independently owned pharmacies, each with a street address, a phone number and a website, and the telehealth consent names the prescribing practices. Price works the other way. Every price only appears inside the intake: nothing carries a figure until you finish a sixteen-screen quiz that ends by asking for your name, email address and phone number, and the figure it then shows already has a welcome coupon applied to it — remove the coupon and the panel rewrites itself to the standing rate.

A telehealth clinic prescribing compounded semaglutide and tirzepatide in all 50 states, with a sublingual line beside the injections. Pricing is genuinely flat by dose — 0.25 mg and the top dose cost the same — and the variable is how long you commit for. Every rung of both ladders is published with the total charge beside the per-month figure, which is more than most of this market does; what it does not do is open on the month-to-month tab.

A membership platform rather than a per-prescription seller: the annual fee buys access and the medication is billed separately each month. Both numbers sit on the site before any intake, in different places. A 21-day trial precedes the first membership charge, and the membership covers unlimited provider messaging, check-ins and dose adjustments.

A straightforward compounded-only program: complete an online assessment, a board-certified U.S.-licensed clinician decides whether to prescribe, and the medication ships. The price is one flat rate that does not move as you titrate — $199/month after a $99 first month — and it covers the medication, the provider access and shipping, with no membership stacked underneath. LegitScript-certified, and its own pages carry the compounded disclaimer in plain terms. The gaps are geographic and informational: it does not ship to Alaska, Mississippi, New Jersey or Kansas, and it never names the pharmacy that compounds what you are injecting.

Curex (Curex, Inc.) started as an allergy-immunotherapy company and now runs a GLP-1 line alongside it. What makes it worth a look on a semaglutide site is the route choice: the same plan covers a weekly compounded injection or an oral dissolving tablet, which is unusual, and California is served on the oral route only. There is no membership fee — the page states $0 — and free shipping is included, with a full refund if a clinician does not prescribe. What is missing is per-drug transparency: the site anchors everything to a single “from $199/mo” plan figure and a $49 first-month sale, and never publishes what an individual medication costs in an ongoing month.

EverSlim runs a deliberately simple offer: one price that its own page says covers the provider visit, the prescription and the delivery, quoted from $117/month for compounded semaglutide and from $140/month for compounded tirzepatide. Coverage is the detail worth knowing — it operates in all fifty states plus DC, but only 44 of those jurisdictions allow the asynchronous questionnaire route; the other seven require a live provider consultation before anything is prescribed. It is LegitScript-certified. The corporate picture is thin: the footer names “CareGLP Affiliated P.C.s” and an affiliated network of medical professional corporations rather than one company, and the compounding pharmacy is not identified.

Alloy is built around one differentiator: every consulting doctor is certified by The Menopause Society, a credential almost nothing else here carries. Compounded semaglutide starts at $70/month, but it is never sold alone — a $99/month Weight Care membership is required alongside it for ongoing clinician messaging, side-effect management and dose adjustments, putting the real floor at $169/month rather than the headline $70. The same membership also gates brand Wegovy and Zepbound and the oral Wegovy pill, so the $99 is a platform toll rather than a one-time add-on. It states outright which seven jurisdictions it does not serve for the compounded medication.

Zealthy (legal entity FitRX LLC, recently operating as Gronk Inc.) advertises compounded semaglutide at a headline price near the bottom of the providers here, filled through independent licensed prescribers in an asynchronous model that does not require a video visit. That low headline is the whole reason to read the rest of the row carefully: the FDA has sent FitRX LLC two separate warning letters for marketing compounded semaglutide and tirzepatide with false or misleading claims — one dated 2025-09-09 (letter 716501, addressed to "FitRX, LLC dba Zealthy") and a second dated 2026-02-20 (letter 717987, addressed to "FitRX, LLC dba FitRx") after a follow-up review found the same violations continuing. Independent reporting also describes an active Novo Nordisk trademark/false-advertising suit and DOJ/FTC scrutiny alleging undisclosed subscription terms and locked cancellation — consistent with the fact that Zealthy's own pricing page does not spell out whether $151/month is the whole bill. The founder previously ran Cerebral, which settled with the FTC in 2024 over comparable allegations.

Nolu is a wellness-branded compounded telehealth seller reaching all 50 states plus Washington, D.C. It compounds semaglutide as both an injectable and a rarer oral tablet, plus tirzepatide, alongside a Microdose GLP-1+B12/NAD+ stack and a separate NAD+/sermorelin line. Every order is priced all-in — consultation, medication and shipping in one figure, with no separate membership fee stacked on top — and the site carries a LegitScript verification badge. The catch is the billing unit: every price on the site, from the $249 semaglutide figure to the $145 wellness floor, is stated "per 4 weeks," not per calendar month, which runs roughly 8% higher over a year than a bare monthly reading suggests. No medical director, prescriber, or compounding pharmacy is named anywhere on the public site.

FORM by GBY (a Las Vegas, NV-registered brand) runs the broadest catalog on this site — compounded semaglutide and tirzepatide in both injectable and oral form, a genuine branded Wegovy/Zepbound membership path, a longevity line (NAD+, sermorelin, GHK-Cu, glutathione) and a hair-loss line (finasteride/minoxidil), all under one account, with LegitScript and HIPAA-compliance badges displayed. The one figure published for the compounded line is $299/month for semaglutide, with no dose tiers shown. The brand-name path is where the page misleads: the advertised "$95/month" for Wegovy is a membership fee only, not the drug cost — the medication itself is billed separately and its price never appears on the page. Tirzepatide, Zepbound, NAD+ and hair-loss pricing are not published at all. No medical director or clinician is named; the pharmacy is described only generically as "US licensed pharmacies."

EdgeRx is a men's-only compounded telehealth brand — its own homepage reads "PRESCRIPTION PROTOCOLS FOR MEN" — offering once-weekly injectable semaglutide and tirzepatide with free shipping and no separate physician fee, alongside a bench of other protocol tiers: MICC lipotropic, a Recovery & Vitality tier, an Energy/Longevity/Cognition tier (sermorelin, NAD+, glutathione, GHK-Cu), a flat Skin/Hair/Aesthetics tier, and a Sexual & Hormonal Health tier whose bloodwork cost is not disclosed. What sets it apart from most of this site is disclosure: it names a Chief Medical Advisor, Dr. John Starke (ABEM board-certified emergency medicine), and — on a dedicated pharmacy page — names its compounding pharmacy outright: Strive Pharmacy, a 503A facility compounding prescription medications since 2018. It is LegitScript certified and claims third-party lab testing, though no specific lab is named. Dr. Starke does not personally prescribe; the actual prescribing pool is unnamed licensed physicians, and the program excludes Arkansas, Indiana, Minnesota and South Carolina.

Lean Meds is a cash-pay weight-loss membership whose one-month semaglutide plan is the cheapest full-dose figure it publishes without a commitment, and it holds that figure at every dose it titrates you to. Prescribing is done by OpenLoop Healthcare Partners, PC, the clinical arm of OpenLoop Health, Inc., which the site's own terms name as the operator of the website. Its FAQ lists the four compounding pharmacies that fill member prescriptions, each with a street address and a phone number, and the footer describes them as state-licensed 503A facilities. The trade-off is paperwork: the rate it advertises from is a twelve-month one, and the site does not agree with itself about which company you are dealing with.

Mondae sells compounded semaglutide and tirzepatide alongside three anti-aging injectables. Both weight-loss prices sit on the public treatment pages with no quiz, no account and no email address — a toggle between the one-month and three-month terms is the only control you need to see them. The figure covers the medication, injection supplies, unlimited clinician messaging and shipping, with no membership or consultation fee, and the site states plainly that it does not move as your dose increases. Telehealth is delivered through Bask Telehealth LLC, named in the terms with a mailing address. The catch is the calendar: what the site calls a month is twenty-eight days.

Alinwell is a Southlake, Texas concierge telehealth selling compounded semaglutide, compounded tirzepatide, a GLP-1 microdose and a daily oral GLP-1, alongside a long peptide catalog. Its distinguishing habit is documentary: each treatment page carries a certificate-of-analysis control, and the certificates it opens name the compounding pharmacy that prepared the batch, the accredited laboratory that tested it, and the formulation — semaglutide compounded with glycine — none of which appears in the site's own writing. Price is the other half of the picture, and it is worse. Every public surface advertises a figure the checkout itself labels a first-month discount, with a higher standing rate struck through beside it, and that rate only appears inside the intake — thirty-one screens in, at the checkout.

Oria Meds sells compounded semaglutide and compounded tirzepatide, each combined with B12, behind a twenty-seven screen intake. The public site never names either molecule: it sells a GLP-1 and a dual GIP/GLP-1, and the drug names appear only once you are inside the questionnaire. What it does name, in the footer of every page, is the pharmacy — PerfectRx of Flower Mound, Texas, with an address and a phone number — which is a good deal more than the price side of the site tells you. The two figures on the homepage match no plan in the menu, and every figure you can actually buy only appears inside the intake, as a first-month rate with the standing rate struck through beside it.

Nex Gen Health Rx runs a three-item weight-loss catalog — compounded semaglutide, compounded tirzepatide and metformin — inside a much broader clinic site. It is unusually open about supply. The footer of every page prints the pharmacy name and its street address, the product pages state the 503A compounding class, and the terms say in plain words that you may direct the prescription to a pharmacy of your own choosing, with an address to write to about it. The checkout is open in a way that helps less: it collects a shipping address and then a card, with no medical question anywhere on that path, and the health questionnaire sits after the payment screen rather than before it.

An online GLP-1 program run by Rx Platform LLC. The full ladder sits on /weightloss before any intake, and the plan card states who dispenses: Manifest Pharmacy, 1018 S. Batesville Road, Greer, SC 29650, with MD Integrations named as the provider network. A licensed provider decides whether treatment is appropriate, and the card says that if it is not, you are not charged for medication.

A telehealth platform operated by RX Web Meds LLC — named in its Terms of Use; the footer names no company. Four programs are sold from homepage cards, each priced "from" a figure, and the drug page a reader clicks through to has no price on it. The eight-screen eligibility flow reaches an email gate without showing one.

Idgie Health is a DBA of Feel Better Health Group, LLC — stated in its own page footer. The ladder is open on the product page before any intake and the plan is stated to cover the provider evaluation, all medication and injection supplies, a dose-titration schedule, unlimited provider messaging and free shipping. Prescriptions ship from a licensed U.S. 503A pharmacy.

A veteran- and firefighter-owned telehealth clinic running hormone care and medical weight loss, with evaluation and prescribing stated as provided by OpenLoop Health. The ladder is on the homepage before any intake and every card carries the same footnote: "Starting price reflects the effective monthly cost when the 52-week option is paid upfront. Medication ships every four weeks."

A published price table rather than a funnel: six programs across semaglutide and tirzepatide, injectable and oral, standard and low-dose, each with four terms priced on one page at /pricing with no intake and no account. The Terms name four independent, state-licensed pharmacies that may dispense, each with a street address and a telephone number.

Operated by Science and Co, Inc., a Delaware corporation. The product page carries one headline price with a struck-through reference figure and a savings percentage, and the FAQ on the same page states what the low number requires. A state-licensed U.S. compounding pharmacy prepares the drug, with every batch described as third-party tested.

Renlo Health LLC, with medical care stated as led by Dr. Sean Arora, MD and prescriptions fulfilled by VialsRX, a named licensed U.S. pharmacy. One price, billed monthly, with a price-lock badge and a four-month money-back guarantee tied to following the plan.

Edessa Group, LLC, at a published Las Vegas address. Three products — GLP-1 injection, GLP-1 tablet and tirzepatide injection — each with a three-rung table on its own product page. The program is stated to include the board-certified provider consultation, the medication, free expedited shipping, ongoing check-ins and dose adjustments, and 24/7 clinical support.